halotestin cycle

Posted on

  In humans, at doses recommended for treatment of patients with chronic obstructive pulmonary disease (50 – 100 mg / day), ARMANORĀ® improves gas exchange function through stimulation of peripheral chemoreceptors aortic and carotid sinus:   The increase in SaO2 and PaO2 Decreasing PaCO2 In applying the drug at the indicated doses observed effects are […]